03.05.26 -- Process Engineering's Key Role In Sterile Injectable Facility Design

Gene therapy development faces complex scientific and regulatory challenges. Success requires optimized vectors, robust preclinical studies, biomarker strategies, and coordinated FDA engagement.

Lipid nanoparticles offer a non-viral alternative for precise T-cell editing. Overcome traditional vector limits; achieve high insertion efficiency and viability in scalable workflows.

Lipid nanoparticles enable precise, non-viral gene editing in T cells to achieve high HDR efficiency and viability in scalable workflows. Explore how this approach overcomes viral vector limitations.

Discover how to improve DNA clean‑up through a precise magnetic bead–based workflow, as well as how optimized liquid handling enhances yield, purity, and reproducibility for higher confidence in results.

Single-use strategies and tools are constantly evolving to better serve industry needs, and adept solutions providers can help streamline development with simple, custom adaptations.

Advance rAAV applications with cost-effective 3D linkage analysis. This comprehensive analytical package ensures genome integrity, supporting the development of safer cell and gene-based therapies.

Optimize your lab's workflow by understanding the trade-offs between rapid high-yielding enzymatic isolation and the superior cell integrity of explant culture for mesenchymal stem cells.

Analyze unit operations and case studies to see how phase-appropriate tools impact the bottom line. Refining your process before automating reduces development timelines and long-term costs.

Scaling EV production requires robust downstream processes. Tailored parameters for therapeutic exosome programs allow for maximum recovery and cost-effective purification at increased volumes.

Site-specific labeling addresses common hurdles in flow cytometry. Enhance assay sensitivity and reduce variability to ensure reliable, reproducible results during CAR-T evaluation protocols.

Join Dr. Stephen Wilmes, PhD, as he explores the critical role of flow cytometry in analyzing CAR-T cell products to focus on identity, purity, potency, and new technologies enhancing assay sensitivity.